NKD2 and breast cancer: In the study of Wang Y et al. [243], lncRNA LINC00922 supported the progression of BC via NKD2 silencing, activating Wnt signaling pathway, and promoting EMT, proliferative, invasive, and migratory capacities of BC cells.